Search by product name, CAS, target or catalog number. Press Down Arrow to reach product suggestions, Tab to move between links, and Escape to close suggestions.
IRE1 inhibitors block inositol-requiring enzyme 1 (IRE1), a sensor of endoplasmic reticulum stress. In 1993, yeast IRE1 was identified as a transmembrane protein kinase required to induce genes for endoplasmic reticulum resident proteins. The enzyme couples a cytosolic kinase domain to an endoribonuclease (RNase) domain. Studies in 2001 and 2002 showed that IRE1 splices X-box binding protein 1 (XBP1) mRNA, producing an active transcription factor of the unfolded protein response. 4μ8C, STF-083010 and MKC8866 inhibit the RNase activity of IRE1α. KIRA6 and Kira8 bind the kinase site and suppress RNase activity allosterically, whereas APY29 is an ATP-competitive ligand of the kinase domain.
IRE1α-IN-2 is a selective inhibitor of IRE1α, demonstrating an IC50 greater than 200 nM for the splicing of XBP1 mRNA. This compound plays a significant role in the study of the unfolded protein response and its implications in cancer research. It is valuable for elucidating the functions of IRE1α in cellular stress pathways and potential therapeutic interventions.
IRE1a-IN-1 is a potent inhibitor of IRE1α, exhibiting an IC50 of less than 100 nM for XBP1 mRNA. This compound plays a significant role in the regulation of the unfolded protein response and is linked to cancer research. It is ideal for studies investigating the therapeutic potential of targeting IRE1α in various cancer types, providing insights into cellular stress responses and tumor biology.
IRE1α kinase-IN-9 is a potent inhibitor of IRE1α, demonstrating an average IC50 value of less than 0.1 μM. This compound is valuable for investigating diseases linked to the unfolded protein response and regulated IRE1-dependent decay (RIDD). Its effectiveness in modulating IRE1α activity makes it a significant tool for research in cellular stress responses and related therapeutic applications.
IRE1α kinase-IN-4 is a selective inhibitor of IRE1α, exhibiting a Ki of 140 nM. This compound acts as an ATP-competitive ligand, effectively blocking the kinase activity of IRE1α. Its biological activity makes it a valuable tool for research in cellular stress responses and the unfolded protein response pathway.
IRE1α kinase-IN-8 is a potent inhibitor of IRE-1α, a key regulator of the unfolded protein response. This compound is primarily utilized in research focused on diseases linked to endoplasmic reticulum stress and the regulation of IRE1-dependent decay (RIDD). Its application may provide valuable insights into therapeutic strategies for conditions associated with protein misfolding and cellular stress responses.
BDM44768 is a selective inhibitor of insulin-degrading enzyme (IDE). This compound has been shown to exacerbate endoplasmic reticulum (ER) stress-induced IRE1 activation, leading to increased lipid accumulation in hepatocytes. BDM44768 serves as a valuable tool in research focused on metabolic disorders and liver function, particularly in models of ER stress and related lipid dysregulation.
1ACTA is an inhibitor of IRE1α S-nitrosylation, effectively preserving the endoplasmic reticulum stress response during nitrosative stress conditions. This compound is essential for studying the regulatory mechanisms of the unfolded protein response (UPR) and its implications in cellular stress responses. It is widely utilized in research investigating pathways related to neurodegeneration, cancer, and metabolic disorders.
Out of stock
All 3 sizes
3,6-DMAD dihydrochloride is a potent inhibitor of the IRE1α-XBP1s signaling pathway, specifically targeting IRE1α oligomerization and endoribonuclease (RNase) activity. This compound has been shown to promote IL-6 secretion, implicating its role in inflammatory responses. 3,6-DMAD dihydrochloride is a valuable tool for cancer research, particularly in studies focusing on cellular stress responses and their implications in tumor biology.
IRE1α kinase-IN-5 is a potent inhibitor of IRE1α, with a Ki value of 98 nM. This ATP-competitive ligand disrupts the activity of IRE1α, a key mediator in the unfolded protein response pathway. Its inhibition of IRE1α activity supports research into cellular stress responses and potential therapeutic targets in diseases linked to dysregulated protein homeostasis.
Out of stock
All 3 sizes
IRE1α kinase-IN-3 is a potent inhibitor of the inositol-requiring enzyme 1 alpha (IRE1α) with an inhibitory constant (Ki) of 480 nM. This compound acts as an ATP-competitive ligand, selectively targeting IRE1α to modulate its kinase activity. IRE1α kinase-IN-3 is valuable for studying the role of IRE1α in the unfolded protein response and related cellular processes, making it a useful tool for research in stress responses and related diseases.
IRE1α kinase-IN-7 is a selective inhibitor of the IRE1α kinase. This compound is valuable for studying endoplasmic reticulum stress-related diseases, as it modulates the IRE1α signaling pathway. Research applications include investigating cellular responses to stress and potential therapeutic avenues in disorders linked to ER stress.
IRE1α kinase-IN-10 is a specific inhibitor of the IRE1α kinase, a key regulator in the unfolded protein response and endoplasmic reticulum stress signaling pathways. This compound is designed for use in research focused on investigating endoplasmic reticulum stress-related diseases, providing insights into cellular stress responses and potential therapeutic strategies. Its application may enhance the understanding of IRE1α's role in various pathological conditions, including neurodegenerative diseases and metabolic disorders.
